AFP and hepatocellular carcinoma: After adjusting for the pre treatment and post-treatment significant factors, we found the 6- month post-treatment platelet level (HR: 0.98, 95% CI: 0.957–0.999, P = 0.038) and AFP level (HR: 1.20, 95% CI: 1.031–1.400, P = 0.019) were independent factors correlated with HCC development (Table 3).